Prestige Consumer Healthcare Inc. (FRA:PBV)
Germany · Delayed Price · Currency is EUR 57.50
+2.00 (3.60%)
At close: Feb 20, 2026
FRA:PBV Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 186.5 | 214.61 | 209.34 | -82.31 | 205.38 | 164.68 |
Depreciation & Amortization | 30.17 | 30.17 | 30.68 | 32.63 | 32.09 | 30.16 |
Other Amortization | 1.78 | 1.75 | 5.24 | 4.36 | 4.23 | 4.98 |
Loss (Gain) From Sale of Assets | 0.29 | 0.23 | 0.27 | 0.27 | 0.27 | 0.22 |
Asset Writedown & Restructuring Costs | 12.47 | 12.47 | - | 370.22 | 1.06 | 2.43 |
Stock-Based Compensation | 10.92 | 11.16 | 14.01 | 12.41 | 9.04 | 8.54 |
Other Operating Activities | 53.42 | 23.07 | 29.22 | -54.01 | 18.8 | 30.18 |
Change in Accounts Receivable | -27.29 | -16.33 | -6.32 | -24.93 | -24.65 | 36.87 |
Change in Inventory | -3 | -9.31 | 24.44 | -42.23 | 0.66 | 2.97 |
Change in Accounts Payable | 17.9 | -19.41 | -24.97 | 7.26 | 9.15 | -17.34 |
Change in Other Net Operating Assets | -6.53 | 3.11 | -32.98 | 6.04 | 3.89 | -28.1 |
Operating Cash Flow | 276.63 | 251.52 | 248.93 | 229.72 | 259.92 | 235.61 |
Operating Cash Flow Growth | 7.82% | 1.04% | 8.36% | -11.62% | 10.32% | 8.51% |
Capital Expenditures | -9.45 | -8.22 | -9.55 | -7.78 | -9.64 | -22.24 |
Cash Acquisitions | -126.51 | -9.23 | -10.56 | -3.8 | -246.87 | - |
Other Investing Activities | -0.95 | - | - | - | - | - |
Investing Cash Flow | -136.91 | -17.45 | -20.11 | -11.58 | -256.51 | -22.24 |
Short-Term Debt Issued | - | - | - | 20 | 85 | - |
Long-Term Debt Issued | - | - | - | - | 597 | 615 |
Total Debt Issued | 40 | - | - | 20 | 682 | 615 |
Short-Term Debt Repaid | - | - | - | -20 | -85 | - |
Long-Term Debt Repaid | - | -139.54 | -227.83 | -137.75 | -602.58 | -866.44 |
Total Debt Repaid | -4.41 | -139.54 | -227.83 | -157.75 | -687.58 | -866.44 |
Net Debt Issued (Repaid) | 35.59 | -139.54 | -227.83 | -137.75 | -5.58 | -251.44 |
Issuance of Common Stock | 6.37 | 14.8 | 18.09 | 7.37 | 7.04 | 2.85 |
Repurchase of Common Stock | -171.17 | -57.34 | -30.51 | -55.47 | -2.92 | -13.11 |
Other Financing Activities | -0.25 | - | -0.77 | - | -6.11 | -17.72 |
Financing Cash Flow | -129.45 | -182.08 | -241.02 | -185.85 | -7.57 | -279.42 |
Foreign Exchange Rate Adjustments | 1.22 | -0.57 | 0.18 | -0.98 | -0.96 | 3.6 |
Net Cash Flow | 11.5 | 51.42 | -12.02 | 31.3 | -5.12 | -62.46 |
Free Cash Flow | 267.19 | 243.29 | 239.38 | 221.93 | 250.28 | 213.36 |
Free Cash Flow Growth | 7.44% | 1.64% | 7.86% | -11.33% | 17.30% | 5.33% |
Free Cash Flow Margin | 24.21% | 21.38% | 21.27% | 19.68% | 23.03% | 22.62% |
Free Cash Flow Per Share | 5.42 | 4.86 | 4.77 | 4.45 | 4.92 | 4.22 |
Cash Interest Paid | 43.7 | 47.8 | 63.25 | 54.24 | 61.36 | 80.29 |
Cash Income Tax Paid | 55.49 | 52.12 | 59.64 | 40.74 | 46.57 | 34.38 |
Levered Free Cash Flow | 207.17 | 188.69 | 177.04 | 165.23 | 200.02 | 160.93 |
Unlevered Free Cash Flow | 231.44 | 216.7 | 213.77 | 204.1 | 235.97 | 207.41 |
Change in Working Capital | -18.92 | -41.94 | -39.83 | -53.86 | -10.95 | -5.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.